The conference will return to the EU and is featuring its Start-Up Hub and Pharmapack Awards.
Pharmapack Europe will return to the European Union on February 7–8, 2018 at the Paris Expo Porte de Versailles, Paris. The conference is currently calling for new applications to its start-up hub platform and for the Pharmapack Awards. The 2018 Start-up Hub is meant to identify innovative new companies.
Start-ups in the inaugural 2017 Start Up Hub spanned the industry; from functional inks that incorporate electronic applications to packaging, to needle-free medicine delivery, to an application that scans packages to provide product information. For 2018, start-ups developing patient-centric packaging or drug delivery solutions in line with connected health and anti-counterfeiting measures are encouraged to apply.
The Pharmapack Awards will also return in 2018. The awards consist of two categories; the Exhibitor Innovation category and, for non-exhibitors, the Health Product category. Exhibitors that take part in the Innovation Gallery automatically enter the Awards for this category, but will still need to complete an entry document for a chance to win.
Pharmapack Award applications are now open for 2018 to companies providing new products. Applications for the 2018 Pharmapack Awards are open until Nov. 3, 2017.
Source: Pharmapack Europe
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025
March 17th 2025This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.